Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Lung
Published in: Lung 3/2014

01-06-2014

A Center’s Experience: Pulmonary Function in Spinal Cord Injury

Authors: Gregory J. Schilero, Miroslav Radulovic, Jill M. Wecht, Ann M. Spungen, William A. Bauman, Marvin Lesser

Published in: Lung | Issue 3/2014

Login to get access

Abstract

Traumatic spinal cord injury (SCI) is associated with significant psychological and physical challenges. A multidisciplinary approach to management is essential to ensure recovery during the acute phase, and comprehensive rehabilitative strategies are necessary to foster independence and quality of life throughout the chronic phase of injury. Complications that beset these individuals are often a unique consequence of SCI, and knowledge of the effects of SCI upon organ systems is essential for appropriate management. According to the National SCI Statistical Center (NSCISC), as of 2010 there were an estimated 265,000 persons living with SCI in the United States, with approximately 12,000 incidence cases annually. Although life expectancy for newly injured individuals with SCI is markedly reduced, persons with chronic SCI are expected to live about as long as individuals without SCI; however, longevity varies inversely with level of injury. Since 2005, 56 % of persons with SCI are tetraplegic, and due to paralysis of respiratory muscles, these individuals may be especially prone to pulmonary complications, which remain a major cause of mortality among persons with chronic SCI. We at the VA Rehabilitation Research and Development Center of Excellence for the Medical Consequences of SCI at the James J. Peters VA Medical Center have devoted more than 25 years to the study of secondary medical conditions that complicate SCI. Herein, we review pulmonary research at the Center, both our past and future endeavors, which form an integral part of our multidisciplinary approach toward achieving a greater understanding of and improving care for veterans with SCI.
Literature
1.
Stone DJ, Keltz H (1963) The effect of respiratory muscle dysfunction on pulmonary function. Studies in patients with spinal cord injuries. Am Rev Respir Dis 88:621–629PubMed
2.
3.
Fugl-Meyer AR (1971) Effects of respiratory muscle paralysis in tetraplegic and paraplegic patients. Scand J Rehabil Med 3(4):141–150PubMed
4.
Fugl-Meyer AR, Grimby G (1971) Ventilatory function in tetraplegic patients. Scand J Rehabil Med 3(4):151–160PubMed
5.
Ohry A, Molho M, Rozin R (1975) Alterations of pulmonary function in spinal cord injured patients. Paraplegia 13(2):101–108CrossRefPubMed
6.
Kokkola K, Moller K, Lehtonen T (1975) Pulmonary function in tetraplegic and paraplegic patients. Ann Clin Res 7(2):76–79PubMed
7.
Forner JV (1980) Lung volumes and mechanics of breathing in tetraplegics. Paraplegia 18(4):258–266CrossRefPubMed
8.
Bluechardt MH et al (1992) Repeated measurements of pulmonary function following spinal cord injury. Paraplegia 30(11):768–774CrossRefPubMed
9.
Roth EJ et al (1995) Pulmonary function testing in spinal cord injury: correlation with vital capacity. Paraplegia 33(8):454–457CrossRefPubMed
10.
Almenoff PL et al (1995) Pulmonary function survey in spinal cord injury: influences of smoking and level and completeness of injury. Lung 173(5):297–306CrossRefPubMed
11.
Linn WS et al (2000) Pulmonary function in chronic spinal cord injury: a cross-sectional survey of 222 southern California adult outpatients. Arch Phys Med Rehabil 81(6):757–763CrossRefPubMed
12.
Linn WS et al (2001) Forced vital capacity in two large outpatient populations with chronic spinal cord injury. Spinal Cord 39(5):263–268CrossRefPubMed
13.
14.
De Troyer A, Heilporn A (1980) Respiratory mechanics in quadriplegia. The respiratory function of the intercostal muscles. Am Rev Respir Dis 122(4):591–600PubMed
15.
Scanlon PD et al (1989) Respiratory mechanics in acute quadriplegia. Lung and chest wall compliance and dimensional changes during respiratory maneuvers. Am Rev Respir Dis 139(3):615–620CrossRefPubMed
16.
Estenne M, De Troyer A (1985) Relationship between respiratory muscle electromyogram and rib cage motion in tetraplegia. Am Rev Respir Dis 132(1):53–59PubMed
17.
De Troyer A, Estenne M, Vincken W (1986) Rib cage motion and muscle use in high tetraplegics. Am Rev Respir Dis 133(6):1115–1119PubMed
18.
Manning H et al (1992) Oxygen cost of resistive-loaded breathing in quadriplegia. J Appl Physiol 73(3):825–831PubMed
19.
DeVivo MJ, Krause JS, Lammertse DP (1999) Recent trends in mortality and causes of death among persons with spinal cord injury. Arch Phys Med Rehabil 80(11):1411–1419CrossRefPubMed
20.
Spungen AM et al (1993) Pulmonary obstruction in individuals with cervical spinal cord lesions unmasked by bronchodilator administration. Paraplegia 31(6):404–407CrossRefPubMed
21.
Almenoff PL et al (1995) Bronchodilatory effects of ipratropium bromide in patients with tetraplegia. Paraplegia 33(5):274–277CrossRefPubMed
22.
Butler J et al (1960) Physiological factors affecting airway resistance in normal subjects and in patients with obstructive respiratory disease. J Clin Invest 39:584–591PubMedCentralCrossRefPubMed
23.
Van Noord JA et al (1994) Assessment of reversibility of airflow obstruction. Am J Respir Crit Care Med 150(2):551–554CrossRefPubMed
24.
Schilero GJ et al (2005) Assessment of airway caliber and bronchodilator responsiveness in subjects with spinal cord injury. Chest 127(1):149–155CrossRefPubMed
25.
Radulovic M et al (2008) Airflow obstruction and reversibility in spinal cord injury: evidence for functional sympathetic innervation. Arch Phys Med Rehabil 89(12):2349–2353CrossRefPubMed
26.
Dicpinigaitis PV et al (1994) Bronchial hyperresponsiveness after cervical spinal cord injury. Chest 105(4):1073–1076CrossRefPubMed
27.
Singas E et al (1996) Airway hyperresponsiveness to methacholine in subjects with spinal cord injury. Chest 110(4):911–915CrossRefPubMed
28.
Grimm DR et al (1999) Airway hyperresponsiveness to ultrasonically nebulized distilled water in subjects with tetraplegia. J Appl Physiol 86(4):1165–1169PubMed
29.
Fein ED et al (1998) The effects of ipratropium bromide on histamine-induced bronchoconstriction in subjects with cervical spinal cord injury. J Asthma 35(1):49–55CrossRefPubMed
30.
Grimm DR et al (2000) Airway hyperreactivity in subjects with tetraplegia is associated with reduced baseline airway caliber. Chest 118(5):1397–1404CrossRefPubMed
31.
Cockcroft DW, Davis BE (2006) Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol 118(3):551–559 quiz 560–561CrossRefPubMed
32.
Dicpinigaitis PV et al (1994) Inhibition of bronchial hyperresponsiveness by the GABA-agonist baclofen. Chest 106(3):758–761CrossRefPubMed
33.
Singas E et al (1999) Inhibition of airway hyperreactivity by oxybutynin chloride in subjects with cervical spinal cord injury. Spinal Cord 37(4):279–283CrossRefPubMed
34.
DeLuca RV et al (1999) Effects of a beta2-agonist on airway hyperreactivity in subjects with cervical spinal cord injury. Chest 115(6):1533–1538CrossRefPubMed
35.
Spungen AM et al (1997) Self-reported prevalence of pulmonary symptoms in subjects with spinal cord injury. Spinal Cord 35(10):652–657CrossRefPubMed
36.
Spungen AM et al (2002) Relationship of respiratory symptoms with smoking status and pulmonary function in chronic spinal cord injury. J Spinal Cord Med 25(1):23–27PubMed
37.
Lougheed MD et al (2002) Respiratory sensation and ventilatory mechanics during induced bronchoconstriction in spontaneously breathing low cervical quadriplegia. Am J Respir Crit Care Med 166(3):370–376CrossRefPubMed
38.
Gounden P (1997) Static respiratory pressures in patients with post-traumatic tetraplegia. Spinal Cord 35(1):43–47CrossRefPubMed
39.
40.
De Troyer A, Estenne M, Heilporn A (1986) Mechanism of active expiration in tetraplegic subjects. N Engl J Med 314(12):740–744CrossRefPubMed
41.
Fujiwara T, Hara Y, Chino N (1999) Expiratory function in complete tetraplegics: study of spirometry, maximal expiratory pressure, and muscle activity of pectoralis major and latissimus dorsi muscles. Am J Phys Med Rehabil 78(5):464–469CrossRefPubMed
42.
Van Houtte S, Vanlandewijck Y, Gosselink R (2006) Respiratory muscle training in persons with spinal cord injury: a systematic review. Respir Med 100(11):1886–1895CrossRefPubMed
43.
Estenne M et al (1989) The effect of pectoralis muscle training in tetraplegic subjects. Am Rev Respir Dis 139(5):1218–1222CrossRefPubMed
44.
DiMarco AF (2005) Restoration of respiratory muscle function following spinal cord injury. Review of electrical and magnetic stimulation techniques. Respir Physiol Neurobiol 147(2–3):273–287CrossRefPubMed
45.
Signorile JF et al (1995) Increased muscle strength in paralyzed patients after spinal cord injury: effect of beta-2 adrenergic agonist. Arch Phys Med Rehabil 76(1):55–58CrossRefPubMed
46.
Murphy RJ et al (1999) Salbutamol effect in spinal cord injured individuals undergoing functional electrical stimulation training. Arch Phys Med Rehabil 80(10):1264–1267CrossRefPubMed
47.
Grimm DR et al (2006) Salmeterol improves pulmonary function in persons with tetraplegia. Lung 184(6):335–339CrossRefPubMed
48.
Schilero GJ et al (2004) Bronchodilator responses to metaproterenol sulfate among subjects with spinal cord injury. J Rehabil Res Dev 41(1):59–64CrossRefPubMed
49.
Jackson AB, Groomes TE (1994) Incidence of respiratory complications following spinal cord injury. Arch Phys Med Rehabil 75(3):270–275CrossRefPubMed
50.
Gris D, Hamilton EF, Weaver LC (2008) The systemic inflammatory response after spinal cord injury damages lungs and kidneys. Exp Neurol 211(1):259–270CrossRefPubMed
51.
Wang TD et al (2007) Circulating levels of markers of inflammation and endothelial activation are increased in men with chronic spinal cord injury. J Formos Med Assoc 106(11):919–928CrossRefPubMed
52.
Radulovic M et al (2010) Exhaled Nitric oxide levels are elevated in persons with tetraplegia and comparable to that in mild asthmatics. Lung 188(3):259–262CrossRefPubMed
53.
54.
Radulovic M, Schilero GJ, Wecht JM, La Fountaine M, Rosado-Rivera D, Bauman W (2011) Comparison of exhaled breath condensate inflammatory biomarker profiles among persons with tetraplegia, asthma and able-bodied controls. Presented at the Paralyzed Veterans of America’s Summit 2011, Orlando, FL
55.
56.
Shimizu Y et al (2009) Assessment of airway inflammation by exhaled breath condensate and impedance due to gastroesophageal reflux disease (GERD). Inflamm Allergy Drug Targets 8(4):292–296CrossRefPubMed
57.
Shimizu Y et al (2007) Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux disease. Respiration 74(5):558–564CrossRefPubMed
58.
Short DJ, Stradling JR, Williams SJ (1992) Prevalence of sleep apnoea in patients over 40 years of age with spinal cord lesions. J Neurol Neurosurg Psychiatry 55(11):1032–1036PubMedCentralCrossRefPubMed
59.
60.
Stockhammer E et al (2002) Characteristics of sleep apnea syndrome in tetraplegic patients. Spinal Cord 40(6):286–294CrossRefPubMed
61.
Leduc BE et al (2007) Estimated prevalence of obstructive sleep apnea–hypopnea syndrome after cervical cord injury. Arch Phys Med Rehabil 88(3):333–337CrossRefPubMed
62.
Young T et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328(17):1230–1235CrossRefPubMed
63.
Schilero GJ et al (2009) Pulmonary function and spinal cord injury. Respir Physiol Neurobiol 166(3):129–141CrossRefPubMed
64.
Narkiewicz K, Somers VK (2003) Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 177(3):385–390CrossRefPubMed
Metadata
Title
A Center’s Experience: Pulmonary Function in Spinal Cord Injury
Authors
Gregory J. Schilero
Miroslav Radulovic
Jill M. Wecht
Ann M. Spungen
William A. Bauman
Marvin Lesser
Publication date
01-06-2014
Publisher
Springer US
Published in
Lung / Issue 3/2014
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-014-9575-8

Other articles of this Issue 3/2014

Lung 3/2014 Go to the issue

OriginalPaper

SS18-Bronchial Biphasic Synovial Sarcoma in an Octogenarian with Hemothorax

OriginalPaper

The Impact of Low Subcutaneous Fat in Patients with Nontuberculous Mycobacterial Lung Disease

OriginalPaper

Exercise Limitation in IPF Patients: A Randomized Trial of Pulmonary Rehabilitation

OriginalPaper

Genetic Influence on Capillary Oxygen Saturation: A Twin Study

OriginalPaper

Progression and Prognostic Indicators of Bronchial Disease in Children with Sickle Cell Disease

OriginalPaper

Prognostic Value of Central Venous Oxygen Saturation and Blood Lactate Levels Measured Simultaneously in the Same Patients with Severe Systemic Inflammatory Response Syndrome and Severe Sepsis
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits